BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Itamoto T, Nakahara H, Amano H, Kohashi T, Ohdan H, Tashiro H, Asahara T. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery. 2007;141:589-597. [PMID: 17462458 DOI: 10.1016/j.surg.2006.12.014] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Milana F, Polidoro MA, Famularo S, Lleo A, Boldorini R, Donadon M, Torzilli G. Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence. Cancers (Basel) 2023;15. [PMID: 36672457 DOI: 10.3390/cancers15020508] [Reference Citation Analysis]
2 Lv TR, Hu HJ, Ma WJ, Hu YF, Dai YS, Li FY. The role of laparoscopic surgery in the surgical management of recurrent liver malignancies: A systematic review and meta-analysis. Front Surg 2022;9:1042458. [PMID: 36684258 DOI: 10.3389/fsurg.2022.1042458] [Reference Citation Analysis]
3 De Carlis R, Lauterio A, Ficarelli A, Vella I, De Carlis L. “Re-Do” Surgery for Hepatocellular Carcinoma: Indications and Results. Hepatocellular Carcinoma 2023. [DOI: 10.1007/978-3-031-09371-5_18] [Reference Citation Analysis]
4 Zhang Y, Xu Z, Yin H, Zhao X, Jiang B, Gao Y, Tan Y. Radiofrequency ablation compared with repeat hepatectomy for patients with recurrent hepatocellular carcinoma: A meta-analysis. Journal of Radiation Research and Applied Sciences 2022;15:100478. [DOI: 10.1016/j.jrras.2022.100478] [Reference Citation Analysis]
5 Iaria M, Bianchi G, Fazio F, Ardito F, Perri P, Pontarolo N, Conci S, Donadon M, Zanello M, Lai Q, Famularo S, Molfino S, Sciannamea I, Fumagalli L, Germani P, Floridi A, Ferrari C, Zimmitti G, Troci A, Zago M, Ferraro V, Cipriani F, Patauner S, La Barba G, Romano M, Zanus G, Ercolani G, Frena A, Aldrighetti L, Memeo R, Pinotti E, Crespi M, Hilal MA, Griseri G, Tarchi P, Chiarelli M, Antonucci A, Baiocchi GL, Romano F, Rossi M, Jovine E, Torzilli G, Ruzzenente A, Maestri M, Grazi GL, Giuliante F, Ferrero A, Dalla Valle R; HE.RC.O.LE.S. GROUP. The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group. HPB (Oxford) 2022;24:1291-304. [PMID: 35125292 DOI: 10.1016/j.hpb.2022.01.001] [Reference Citation Analysis]
6 Chen Z, Wang J, Lin Y. Comparison of the efficacy and safety of repeated hepatectomy and radiofrequency ablation in the treatment of primary recurrent liver cancer: a meta-analysis. World J Surg Oncol 2022;20:182. [PMID: 35668464 DOI: 10.1186/s12957-022-02649-4] [Reference Citation Analysis]
7 Bednarsch J, Czigany Z, Heij LR, Amygdalos I, Heise D, Bruners P, Ulmer TF, Neumann UP, Lang SA. The role of re-resection in recurrent hepatocellular carcinoma. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02545-1] [Reference Citation Analysis]
8 Shigematsu Y, Amori G, Kanda H, Takahashi Y, Takazawa Y, Takeuchi K, Inamura K. Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma. Virchows Arch 2022. [PMID: 35459975 DOI: 10.1007/s00428-022-03318-3] [Reference Citation Analysis]
9 Aquina CT, Eskander MF, Pawlik TM. Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature. Front Oncol 2022;12:832405. [DOI: 10.3389/fonc.2022.832405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zheng X, Ren Y, Hu H, Qian K. Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative Study. Front Oncol 2021;11:713432. [PMID: 34568043 DOI: 10.3389/fonc.2021.713432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Imaoka Y, Ohira M, Sato K, Imaoka K, Kuroda S, Tahara H, Kobayashi T, Ide K, Tanaka Y, Ohdan H. Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Chen ZY, Guo ZX, Lu LH, Mei J, Lin WP, Li SH, Wei W, Guo RP. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma. Cancer Med 2021;10:5466-74. [PMID: 34212527 DOI: 10.1002/cam4.4102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Miyama A, Morise Z, Aldrighetti L, Belli G, Ratti F, Cheung TT, Lo CM, Tanaka S, Kubo S, Okamura Y, Uesaka K, Monden K, Sadamori H, Hashida K, Kawamoto K, Gotohda N, Chen K, Kanazawa A, Takeda Y, Ohmura Y, Ueno M, Ogura T, Suh KS, Kato Y, Sugioka A, Belli A, Nitta H, Yasunaga M, Cherqui D, Halim NA, Laurent A, Kaneko H, Otsuka Y, Kim KH, Cho HD, Lin CC, Ome Y, Seyama Y, Troisi RI, Berardi G, Rotellar F, Wilson GC, Geller DA, Soubrane O, Yoh T, Kaizu T, Kumamoto Y, Han HS, Ekmekcigil E, Dagher I, Fuks D, Gayet B, Buell JF, Ciria R, Briceno J, O'Rourke N, Lewin J, Edwin B, Shinoda M, Abe Y, Hilal MA, Alzoubi M, Tanabe M, Wakabayashi G. Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels. Cancers (Basel) 2021;13:3187. [PMID: 34202373 DOI: 10.3390/cancers13133187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liu Y, Ren Y, Ge S, Xiong B, Zhou G, Feng G, Song S, Zheng C. Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome and Risk Signature Analysis. Front Oncol 2021;11:662408. [PMID: 34155478 DOI: 10.3389/fonc.2021.662408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Takase K, Sakamoto T, Takeda Y, Ohmura Y, Katsura Y, Shinke G, Kawai K, Murakami K, Kagawa Y, Masuzawa T, Takeno A, Hata T, Murata K. Safety and efficacy of laparoscopic repeat liver resection and re-operation for liver tumor. Sci Rep 2021;11:11605. [PMID: 34078927 DOI: 10.1038/s41598-021-89864-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Famularo S, Donadon M, Cipriani F, Bernasconi DP, LaBarba G, Dominioni T, Iaria M, Molfino S, Conci S, Ferrari C, Garatti M, Delvecchio A, Troci A, Patauner S, Frassani S, Cosimelli M, Zanus G, Giuliante F, Jovine E, Valsecchi MG, Grazi G, Antonucci A, Frena A, Crespi M, Memeo R, Zimmitti G, Griseri G, Ruzzenente A, Baiocchi G, DallaValle R, Maestri M, Ercolani G, Aldrighetti L, Torzilli G, Romano F; HE.RC.O.LE.S. Group. Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison. HPB (Oxford) 2021;23:889-98. [PMID: 33144053 DOI: 10.1016/j.hpb.2020.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chua DW, Koh YX, Syn NL, Chuan TY, Yao TJ, Lee SY, Goh BKP, Cheow PC, Chung AY, Chan CY. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis. Ann Surg Oncol 2021. [PMID: 33969464 DOI: 10.1245/s10434-021-09948-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Mahamid A, Berger Y, Halim NA, Goldberg N, Sawaied M, Bitterman A, Sadot E, Haddad R. Hand-assisted Laparoscopic Repeat Hepatectomy for Secondary Liver Neoplasm. Surg Laparosc Endosc Percutan Tech 2020;30:233-7. [PMID: 31985572 DOI: 10.1097/SLE.0000000000000760] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Fang Q, Yang R, Chen D, Fei R, Chen P, Deng K, Gao J, Liao W, Chen H. A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma. Front Oncol 2021;11:646638. [PMID: 33842361 DOI: 10.3389/fonc.2021.646638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Federico P, Giunta EF, Pappalardo A, Tufo A, Marte G, Attademo L, Fabbrocini A, Petrillo A, Daniele B. How to Treat Hepatocellular Carcinoma in Elderly Patients. Pharmaceuticals (Basel) 2021;14:233. [PMID: 33800217 DOI: 10.3390/ph14030233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Cai J, Zheng J, Xie Y, Kirih MA, Tao L, Liang X. Laparoscopic repeat hepatectomy for treating recurrent liver cancer. J Minim Access Surg 2021;17:1-6. [PMID: 31603081 DOI: 10.4103/jmas.JMAS_187_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yang D, Zhuang B, Wang Y, Xie X, Xie X. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis. BMC Gastroenterol 2020;20:402. [PMID: 33246417 DOI: 10.1186/s12876-020-01544-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
23 Okimoto S, Tashiro H, Iwako H, Kuroda S, Kobayashi T, Hinoi T, Ohdan H. Antithrombin attenuates the progression of hepatocellular carcinoma by regulating neutrophil/interleukin-8 signaling. Hepatol Res. 2020;50:1284-1296. [PMID: 32893935 DOI: 10.1111/hepr.13558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Onoe T, Yamaguchi M, Irei T, Ishiyama K, Sudo T, Hadano N, Kojima M, Kubota H, Ide R, Tazawa H, Shimizu W, Suzuki T, Shimizu Y, Hinoi T, Tashiro H. Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma. Surg Endosc 2020;34:4574-81. [PMID: 31853630 DOI: 10.1007/s00464-019-07246-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
25 Jin H, Chalkidou A, Hawkins M, Summers J, Eddy S, Peacock JL, Coker B, Kartha MR, Good J, Pennington M; SABR Data Working Group. Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcinoma. Clin Oncol (R Coll Radiol) 2021;33:e143-54. [PMID: 32951952 DOI: 10.1016/j.clon.2020.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li X, Hu J, Gu B, Paul ME, Wang B, Yu Y, Feng Z, Ma Y, Wang X, Chen H. Animal model of intrahepatic metastasis of hepatocellular carcinoma: establishment and characteristic. Sci Rep 2020;10:15199. [PMID: 32939004 DOI: 10.1038/s41598-020-72110-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ding M, Zhao X, Zhao M, Shi Y, Wang T, Cui D, Shi D, Zhai B. Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation. Cardiovasc Intervent Radiol 2020;43:1621-30. [PMID: 32814990 DOI: 10.1007/s00270-020-02617-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Yamamoto M, Kobayashi T, Mashima H, Miki D, Kuroda S, Hamaoka M, Aikata H, Chayama K, Ohdan H. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study. Int J Surg 2020;80:84-90. [PMID: 32615319 DOI: 10.1016/j.ijsu.2020.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Morise Z. Laparoscopic repeat liver resection. Ann Gastroenterol Surg 2020;4:485-9. [PMID: 33005842 DOI: 10.1002/ags3.12363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Lu LH, Mei J, Kan A, Ling YH, Li SH, Wei W, Chen MS, Zhang YF, Guo RP. Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation. Cancer Med. 2020;9:2997-3005. [PMID: 32108433 DOI: 10.1002/cam4.2951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
31 Morise Z, Aldrighetti L, Belli G, Ratti F, Belli A, Cherqui D, Tanabe M, Wakabayashi G; ILLS-Tokyo Collaborator group. Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. Br J Surg 2020;107:889-95. [PMID: 31994182 DOI: 10.1002/bjs.11436] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
32 Xing H, Sun LY, Yan WT, Quan B, Liang L, Li C, Zhou YH, Wang H, Zhong JH, Gu WM, Chen TH, Wang MD, Wu H, Pawlik TM, Lau WY, Wu MC, Shen F, Yang T. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis. Surgery 2021;169:911-20. [PMID: 31879090 DOI: 10.1016/j.surg.2019.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
33 Yamamoto M, Kobayashi T, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka Y, Honmyo N, Ohdan H. Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO). Surg Endosc 2020;34:5055-61. [PMID: 31828498 DOI: 10.1007/s00464-019-07302-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
34 Guo Y, Tan EK, Syn NL, Krishnamoorthy TL, Tan CK, Lim R, Lee SY, Chan CY, Cheow PC, Chung AYF, Jeyaraj PR, Goh BKP. Repeat liver resection vs salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis. Ann Hepatobiliary Pancreat Surg. 2019;23:305-312. [PMID: 31824994 DOI: 10.14701/ahbps.2019.23.4.305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
35 Ome Y, Honda G, Doi M, Muto J, Seyama Y. Laparoscopic Anatomic Liver Resection of Segment 8 Using Intrahepatic Glissonean Approach. J Am Coll Surg 2020;230:e13-20. [PMID: 31783094 DOI: 10.1016/j.jamcollsurg.2019.11.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
36 Blüthner E, Bednarsch J, Malinowski M, Binder P, Pratschke J, Stockmann M, Kaffarnik M. Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - A retrospective cohort study. International Journal of Surgery 2019;71:56-65. [DOI: 10.1016/j.ijsu.2019.08.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
37 Peng Y, Liu F, Wei Y, Li B. Outcomes of laparoscopic repeat liver resection for recurrent liver cancer: A system review and meta-analysis. Medicine (Baltimore) 2019;98:e17533. [PMID: 31593128 DOI: 10.1097/MD.0000000000017533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
38 Xu D, Sheng JQ, Hu PJ, Huang TS, Lee WC. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables. J Biomed Inform 2019;96:103237. [PMID: 31238108 DOI: 10.1016/j.jbi.2019.103237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Guo Y, Chua DW, Koh Y, Lee S, Cheow P, Kam J, Teo J, Chow PK, Chung AY, Ooi LL, Chan C, Goh BKP. Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma. World J Surg 2019;43:2587-94. [DOI: 10.1007/s00268-019-05051-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
40 Peng Z, Chen S, Xiao H, Wang Y, Li J, Mei J, Chen Z, Zhou Q, Feng S, Chen M, Qian G, Peng S, Kuang M. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.Radiology. 2019;292:237-247. [PMID: 31135299 DOI: 10.1148/radiol.2019181818] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
41 Guo Y, Tan EK, Krishnamoorthy TL, Tan CK, Tan BH, Tan TT, Lee SY, Chan CY, Cheow PC, Chung AYF, Jeyaraj PR, Goh BKP. Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant. Ann Hepatobiliary Pancreat Surg 2019;23:1-7. [PMID: 30863801 DOI: 10.14701/ahbps.2019.23.1.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
42 Imaoka Y, Ohira M, Yano T, Nakano R, Tanimine N, Shimizu S, Kuroda S, Tahara H, Kobayashi T, Ohdan H. Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2018;25:370-6. [PMID: 30051596 DOI: 10.1002/jhbp.573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Morise Z. Status and perspective of laparoscopic repeat liver resection. World J Hepatol 2018; 10(7): 479-484 [PMID: 30079134 DOI: 10.4254/wjh.v10.i7.479] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
44 Nakano R, Ohira M, Kobayashi T, Imaoka Y, Mashima H, Yamaguchi M, Honmyo N, Okimoto S, Hamaoka M, Shimizu S, Kuroda S, Tahara H, Ide K, Ohdan H. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study. Int J Surg 2018;57:1-7. [PMID: 30036692 DOI: 10.1016/j.ijsu.2018.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
45 Nakano R, Ohira M, Kobayashi T, Ide K, Tahara H, Kuroda S, Shimizu S, Kimura T, Nagata Y, Aikata H, Chayama K, Ohdan H. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution. Surgery 2018;164:219-26. [PMID: 29801728 DOI: 10.1016/j.surg.2018.03.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
46 Yan PG, Wang RY, Zhang J, Cong WM, Dong H, Yu HY, Lau WY, Wu MC, Zhou WP. Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study. J Gastrointest Surg 2018;22:872-83. [PMID: 29313290 DOI: 10.1007/s11605-017-3638-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
47 Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. Eur Radiol 2018;28:3522-31. [PMID: 29536241 DOI: 10.1007/s00330-017-5166-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
48 Abe T, Tashiro H, Kobayashi T, Hattori M, Kuroda S, Ohdan H. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma. World J Surg 2017;41:1860-70. [PMID: 28197709 DOI: 10.1007/s00268-017-3909-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
49 Pfiffer TE, Seehofer D, Nicolaou A, Neuhaus R, Riess H, Trappe RU. Recurrent hepatocellular carcinoma in liver transplant recipients: Parameters affecting time to recurrence, treatment options and survival in the sorafenib era. Tumori 2011;97:436-41. [DOI: 10.1177/030089161109700404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
50 Harimoto N, Yoshizumi T, Fujimoto Y, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y. Surgery for Hepatocellular Carcinoma in Patients with Child–Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation. World J Surg 2018;42:2606-16. [DOI: 10.1007/s00268-018-4493-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
51 Ome Y, Hashida K, Yokota M, Nagahisa Y, Yamaguchi K, Okabe M, Kawamoto K. The feasibility and efficacy of pure laparoscopic repeat hepatectomy. Surg Endosc. 2018;. [PMID: 29344784 DOI: 10.1007/s00464-018-6066-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
52 Chen S, Peng Z, Xiao H, Lin M, Chen Z, Jiang C, Hu W, Xie X, Liu L, Peng B, Kuang M. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery. Int J Hyperthermia 2018;34:1029-37. [PMID: 28974113 DOI: 10.1080/02656736.2017.1387941] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
53 Sun WC, Chen IS, Liang HL, Tsai CC, Chen YC, Wang BW, Lin HS, Chan HH, Hsu PI, Tsai WL, Cheng JS. Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection. Oncotarget 2017;8:104571-81. [PMID: 29262662 DOI: 10.18632/oncotarget.21604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
54 Okimoto S, Kobayashi T, Kuroda S, Ishiyama K, Ide K, Ohira M, Tahara H, Shimizu S, Iwako H, Hamaoka M, Honmyo N, Yamaguchi M, Ohdan H. Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response. Hepatol Res 2017;47:1186-95. [PMID: 28326662 DOI: 10.1111/hepr.12896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
55 Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K. Salvage hepatectomy for local recurrence of hepatocellular carcinomas offers survival comparable to that of matched patients who undergo primary hepatectomies. Eur J Surg Oncol 2017;43:1076-82. [PMID: 28456443 DOI: 10.1016/j.ejso.2017.03.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Liu K, Chen Y, Wu X, Huang Z, Lin Z, Jiang J, Tan W, Zhang L. Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study. Surg Endosc 2017;31:4790-8. [DOI: 10.1007/s00464-017-5556-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
57 Notake T, Kobayashi A, Shinkawa H, Kawahara T, Shimizu A, Yokoyama T, Hasegawa K, Kokudo N, Matsuyama Y, Makuuchi M, Miyagawa SI. Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection. Int J Clin Oncol 2017;22:715-25. [PMID: 28303401 DOI: 10.1007/s10147-017-1114-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
58 Huang S, Xia Y, Lei Z, Zou Q, Li J, Yang T, Wang K, Yan Z, Wan X, Shen F. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma. Journal of the American College of Surgeons 2017;224:283-293.e4. [DOI: 10.1016/j.jamcollsurg.2016.11.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
59 Gavriilidis P, Askari A, Azoulay D. Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford) 2017;19:3-9. [PMID: 28341429 DOI: 10.1016/j.hpb.2016.10.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
60 Dai WC, Cheung TT. Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence. Expert Rev Anticancer Ther 2016;16:1063-72. [PMID: 27548586 DOI: 10.1080/14737140.2016.1226136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
61 Chong CC, Wong J, Cheung Y, Yu SC, Hui JW, Lee PS, Ip PS, Lee K, Lai PB. Radiofrequency ablation for recurrent versus first-occurrence hepatocellular carcinoma: Ablation for hepatocellular carcinoma. Surg Pract 2016;20:104-9. [DOI: 10.1111/1744-1633.12187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Takamoto T, Sugawara Y, Hashimoto T, Makuuchi M. Evaluating the current surgical strategies for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2016;10:341-57. [PMID: 26558422 DOI: 10.1586/17474124.2016.1116381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
63 Mise Y, Hasegawa K, Shindoh J, Ishizawa T, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N. The Feasibility of Third or More Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma. Ann Surg. 2015;262:347-357. [PMID: 25185473 DOI: 10.1097/sla.0000000000000882] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
64 Lu J, Xiong XZ, Li FY, Ye H, Lin YX, Zhou RX, Cai YL, Jin YW, Cheng NS. Prognostic Significance of Sarcomatous Change in Patients with Hepatocellular Carcinoma After Surgical Resection. Ann Surg Oncol. 2015;22 Suppl 3:S1048-S1056. [PMID: 26286198 DOI: 10.1245/s10434-015-4818-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
65 Zu QQ, Liu S, Zhou CG, Yang ZQ, Xia JG, Zhao LB, Shi HB. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors. AJR Am J Roentgenol 2015;204:1322-8. [PMID: 26001244 DOI: 10.2214/AJR.14.13343] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
66 Chen X, Chen Y, Li Q, Ma D, Shen B, Peng C. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis. Journal of Surgical Research 2015;195:166-74. [DOI: 10.1016/j.jss.2015.01.042] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
67 Fukuhara T, Aikata H, Hyogo H, Honda Y, Morio K, Morio R, Hatooka M, Kobayashi T, Naeshiro N, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Chayama K. Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases. Eur J Radiol 2015;84:1540-5. [PMID: 25979193 DOI: 10.1016/j.ejrad.2015.04.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
68 Sadykov N, Soyama A, Hidaka M, Kinoshita A, Takatsuki M, Adachi T, Kitasato A, Fujita F, Kuroki T, Eguchi S. Peritoneal recurrence of initially controlled hepatocellular carcinoma after living donor liver transplantation. Case Rep Gastroenterol 2015;9:29-35. [PMID: 25802495 DOI: 10.1159/000375117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Cai H, Kong W, Zhou T, Qiu Y. Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore) 2014;93:e122. [PMID: 25396332 DOI: 10.1097/MD.0000000000000122] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
70 Isetani M, Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S. Pure laparoscopic hepatectomy as repeat surgery and repeat hepatectomy. World J Gastroenterol 2015; 21(3): 961-968 [PMID: 25624731 DOI: 10.3748/wjg.v21.i3.961] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
71 Song KD, Lim HK, Rhim H, Lee MW, Kim YS, Lee WJ, Paik YH, Gwak GY, Kim JM, Kwon CH. Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study. Radiology. 2015;275:599-608. [PMID: 25559235 DOI: 10.1148/radiol.14141568] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
72 Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma. World J Hepatol 2014; 6(12): 836-843 [PMID: 25544870 DOI: 10.4254/wjh.v6.i12.836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
73 Oishi K, Itamoto T, Kohashi T, Matsugu Y, Nakahara H, Kitamoto M. Safety of hepatectomy for elderly patients with hepatocellular carcinoma. World J Gastroenterol 2014; 20(41): 15028-15036 [PMID: 25386051 DOI: 10.3748/wjg.v20.i41.15028] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
74 Gaddikeri S, Mcneeley MF, Wang CL, Bhargava P, Dighe MK, Yeh MMC, Dubinsky TJ, Kolokythas O, Lalwani N. Hepatocellular Carcinoma in the Noncirrhotic Liver. American Journal of Roentgenology 2014;203:W34-47. [DOI: 10.2214/ajr.13.11511] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
75 Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. J Gastroenterol Hepatol 2014;29:1056-64. [PMID: 24372785 DOI: 10.1111/jgh.12507] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
76 Mise Y, Satou S, Ishizawa T, Kaneko J, Aoki T, Hasegawa K, Sugawara Y, Makuuchi M, Kokudo N. Impact of Surgery on Quality of Life in Patients with Hepatocellular Carcinoma. World J Surg 2014;38:958-67. [DOI: 10.1007/s00268-013-2342-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
77 Ahn SH, Kim SH, Choi GH, Choi JS, Kim KS. The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma. J Korean Surg Soc 2013;85:269-74. [PMID: 24368984 DOI: 10.4174/jkss.2013.85.6.269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
78 Wong GL, Chong C, Wong VW. Tertiary Prevention of HBV-related HCC in Asia. Curr Hepatitis Rep 2013;12:157-164. [DOI: 10.1007/s11901-013-0171-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Yamashita Y, Shirabe K, Tsuijita E, Takeishi K, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Utsunomiya T, Maehara Y. Third or more repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 2013;154:1038-45. [PMID: 23973109 DOI: 10.1016/j.surg.2013.04.046] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
80 Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma - a systematic review. Surg Oncol 2013;22:e23-30. [PMID: 23535302 DOI: 10.1016/j.suronc.2013.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
81 Schnickel G, Petrowsky H. Resection Transplant in the Treatment of Primary Liver Cancers. Image-Guided Cancer Therapy 2013. [DOI: 10.1007/978-1-4419-0751-6_25] [Reference Citation Analysis]
82 Yin XY, Xie XY, Lu MD, Kuang M, Liu GJ, Xu ZF, Xu HX, Wang Z. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model. Ann Surg Oncol. 2012;19:4300-4306. [PMID: 22766980 DOI: 10.1245/s10434-012-2433-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
83 Sadamori H, Yagi T, Matsuda H, Shinoura S, Umeda Y, Fujiwara T. Intractable bile leakage after hepatectomy for hepatocellular carcinoma in 359 recent cases. Dig Surg 2012;29:149-56. [PMID: 22555445 DOI: 10.1159/000337313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
84 Tsujita E, Yamashita Y, Takeishi K, Matsuyama A, Tsutsui S, Matsuda H, Toshima T, Taketomi A, Shirabe K, Ishida T, Maehara Y. Poor Prognostic Factors after Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma in the Modern Era. The American Surgeon 2012;78:419-25. [DOI: 10.1177/000313481207800431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
85 Sadamori H, Yagi T, Shinoura S, Umeda Y, Yoshida R, Satoh D, Nobuoka D, Utsumi M, Yoshida K, Fujiwara T. Risk factors for organ/space surgical site infection after hepatectomy for hepatocellular carcinoma in 359 recent cases. Journal of Hepato-Biliary-Pancreatic Sciences 2013;20:186-96. [DOI: 10.1007/s00534-011-0503-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
86 Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg. 2011;35:2073-2082. [PMID: 21656309 DOI: 10.1007/s00268-011-1161-0] [Cited by in Crossref: 137] [Cited by in F6Publishing: 129] [Article Influence: 11.4] [Reference Citation Analysis]
87 Duan J, Yue H, Liu K, Wu M, Yang J. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: retrospective randomized control study. Journal of Medical Colleges of PLA 2011;26:316-23. [DOI: 10.1016/s1000-1948(12)60027-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 Liu H, Chen DF, Li RR, Chen WY, Ke EM, Zhang WH, Liu J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma: an analysis of 10 cases. Shijie Huaren Xiaohua Zazhi 2011; 19(27): 2876-2880 [DOI: 10.11569/wcjd.v19.i27.2876] [Reference Citation Analysis]
89 Ahn KS, Han HS, Yoon YS, Cho JY, Kim JH. Laparoscopic liver resection in patients with a history of upper abdominal surgery. World J Surg. 2011;35:1333-1339. [PMID: 21452069 DOI: 10.1007/s00268-011-1073-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
90 Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguchi T. Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg. 2011;396:1093-1100. [PMID: 21847622 DOI: 10.1007/s00423-011-0837-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
91 Roayaie S, Bassi D, Tarchi P, Labow D, Schwartz M. Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol 2011;55:346-50. [PMID: 21147184 DOI: 10.1016/j.jhep.2010.11.026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
92 Faber W, Seehofer D, Neuhaus P, Stockmann M, Denecke T, Kalmuk S, Warnick P, Bahra M. Repeated liver resection for recurrent hepatocellular carcinoma. J Gastroenterol Hepatol 2011;26:1189-94. [PMID: 21410751 DOI: 10.1111/j.1440-1746.2011.06721.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
93 Tanimoto Y, Tashiro H, Aikata H, Amano H, Oshita A, Kobayashi T, Kuroda S, Tazawa H, Takahashi S, Itamoto T. Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection. Ann Surg Oncol. 2012;19:418-425. [PMID: 21710324 DOI: 10.1245/s10434-011-1866-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
94 Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103. [PMID: 21994868 DOI: 10.4061/2011/728103] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
95 Tashiro H, Aikata H, Waki K, Amano H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, Tazawa H, Chayama K, Asahara T, Ohdan H. Treatment strategy for early hepatocellular carcinomas: Comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection. J Surg Oncol 2011;104:3-9. [DOI: 10.1002/jso.21745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
96 Matsuda M, Asakawa M, Amemiya H, Fujii H. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC. J Gastroenterol Hepatol 2011;26:731-8. [PMID: 21155886 DOI: 10.1111/j.1440-1746.2010.06532.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
97 Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. Hepatocellular Carcinoma: Current Management and Perspectives for the Future. Annals of Surgery 2011;253:453-69. [DOI: 10.1097/sla.0b013e31820d944f] [Cited by in Crossref: 310] [Cited by in F6Publishing: 354] [Article Influence: 25.8] [Reference Citation Analysis]
98 Sadamori H, Yagi T, Matsuda H, Shinoura S, Umeda Y, Yoshida R, Satoh D, Nobuoka D, Utsumi M, Yoshida K, Fujiwara T. RISK FACTORS FOR BILE LEAKAGE AFTER HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA IN 359 RECENT CASES. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 2011;72:2767-2775. [DOI: 10.3919/jjsa.72.2767] [Reference Citation Analysis]
99 Xue XB, Xiao CW, Zhang H, Lu AG, Gao W, Zhou ZQ, Guo XL, Zhong MA, Yang Y, Wang CJ. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines. World J Gastroenterol 2010; 16(37): 4677-4684 [PMID: 20872968 DOI: 10.3748/wjg.v16.i37.4677] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
100 Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J, Liu Z. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 2010;8:55. [PMID: 20591196 DOI: 10.1186/1477-7819-8-55] [Cited by in Crossref: 73] [Cited by in F6Publishing: 82] [Article Influence: 5.6] [Reference Citation Analysis]
101 Sadamori H, Yagi T, Matsuda H, Shinoura S, Umeda Y, Yoshida R, Satoh D, Utsumi T, Ohnishi T. Risk factors for major morbidity after hepatectomy for hepatocellular carcinoma in 293 recent cases. J Hepatobiliary Pancreat Sci. 2010;17:709-718. [PMID: 20703850 DOI: 10.1007/s00534-010-0275-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
102 Choi JW, Park JY, Ahn SH, Yoon KT, Ko HK, Lee DY, Lee JT, Kim KS, Choi JS, Han KH. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection. Am J Clin Oncol. 2009;32:564-569. [PMID: 19564783 DOI: 10.1097/COC.0b013e3181967da0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
103 Tsujita E, Utsunomiya T, Ohta M, Tagawa T, Matsuyama A, Okazaki J, Yamamoto M, Tsutsui S, Ishida T. Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older. Surgery. 2010;147:696-703. [PMID: 20015526 DOI: 10.1016/j.surg.2009.10.054] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
104 Nagano Y, Shimada H, Ueda M, Matsuo K, Tanaka K, Endo I, Kunisaki C, Togo S. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas. ANZ Journal of Surgery 2009;79:729-33. [DOI: 10.1111/j.1445-2197.2009.05059.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
105 Wu CC, Cheng SB, Yeh DC, Wang J, P’eng FK. Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Br J Surg. 2009;96:1049-1057. [PMID: 19672929 DOI: 10.1002/bjs.6690] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
106 Ueno M, Uchiyama K, Ozawa S, Nakase T, Togo N, Hayami S, Yamaue H. Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma. Surg Today 2009;39:675-81. [PMID: 19639434 DOI: 10.1007/s00595-008-3942-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
107 Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Thono E, Tsuboi K, Tokuuye K. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;74:831-836. [PMID: 19304408 DOI: 10.1016/j.ijrobp.2008.10.073] [Cited by in Crossref: 157] [Cited by in F6Publishing: 170] [Article Influence: 11.2] [Reference Citation Analysis]
108 Thelen A, Jonas S, Benckert C, Weichert W, Schott E, Bötcher C, Dietz E, Wiedenmann B, Neuhaus P, Scholz A. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma. Ann Surg Oncol 2009;16:1222-30. [PMID: 19224279 DOI: 10.1245/s10434-009-0380-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
109 Hung BP, Shih KC. Surgery, ablation or combination. J Formos Med Assoc 2008;107:971; author reply 972. [PMID: 19129060 DOI: 10.1016/S0929-6646(09)60023-1] [Reference Citation Analysis]
110 Liang HH, Chen MS, Peng ZW, Zhang YJ, Zhang YQ, Li JQ, Lau WY. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol. 2008;15:3484-3493. [PMID: 18679754 DOI: 10.1245/s10434-008-0076-y] [Cited by in Crossref: 83] [Cited by in F6Publishing: 93] [Article Influence: 5.5] [Reference Citation Analysis]
111 Choi G, Kim D, Kang C, Kim K, Choi J, Lee W, Kim B. Prognostic Factors and Optimal Treatment Strategy for Intrahepatic Nodular Recurrence After Curative Resection of Hepatocellular Carcinoma. Ann Surg Oncol 2008;15:618-29. [DOI: 10.1245/s10434-007-9671-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]